It has been reported that the expression of SLPI is up-regulated in some types of tumors such as non-small cell lung cancer, prostate cancer, inflammatory breast cancer and ovarian cancer, which could play a promoting role in tumor progression 19-21. This evidence concerns the gene SLPI and non-small cell lung carcinoma.